| Literature DB >> 33193165 |
Rui-Si Hu1,2, Jun-Jun He1, Hany M Elsheikha3, Yang Zou1, Muhammad Ehsan1, Qiao-Ni Ma1, Xing-Quan Zhu1,4, Wei Cong5.
Abstract
Infection by the protozoan Toxoplasma gondii can have a devastating impact on the structure and function of the brain of the infected individuals, particularly immunocompromised patients. A systems biology view of the brain transcriptome can identify key molecular targets and pathways that mediate the neuropathogenesis of cerebral toxoplasmosis. Here, we performed transcriptomic analysis of the brain of mice infected by T. gondii Pru strain oocysts at 11 and 33 days post-infection (dpi) compared to uninfected (control) mice using RNA sequencing (RNA-seq). T. gondii altered the expression of 936 and 2,081 transcripts at 11 and 33 dpi, respectively, and most of these were upregulated in the infected brains. Gene Ontology (GO) enrichment and pathway analysis showed that immune response, such as interferon-gamma (IFN-γ) responsive genes were strongly affected at 11dpi. Likewise, differentially expressed transcripts (DETs) related to T cell activation, cytokine production and immune cell proliferation were significantly altered at 33 dpi. Host-parasite interactome analysis showed that some DETs were involved in immune signaling, metabolism, biosynthesis-related processes and interspecies interaction. These findings should increase knowledge of the mouse brain transcriptome and the changes in transcriptional regulation and downstream signaling pathways during acute and chronic T. gondii infections.Entities:
Keywords: RNA-seq; Toxoplasma gondii; cerebral toxoplasmosis; host-parasite interaction; oocysts; transcriptome
Year: 2020 PMID: 33193165 PMCID: PMC7604304 DOI: 10.3389/fmicb.2020.570903
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
FIGURE 1Detection of T. gondii B1 gene amplified by specific semi-nested PCR in infected and uninfected mouse brain tissues. The amplified band of 98 bp was detected in infected mouse brain (11 and 33 dpi). However, no product was detected in the brain tissues of uninfected mice at the same time points. Lane M: 500 bp DNA molecular ladder; Lane P: positive control; Lane N: negative control; Lanes 1–3: infected brain tissues at 11 dpi; Lanes 4–6: infected brain tissues at 33 dpi; Lanes 7–9: uninfected brain tissues at 11 dpi; Lanes 10–12: uninfected brain tissues at 33 dpi.
Characteristics of the RNA-seq results obtained in the present study.
| Mouse groups | Sample code | Raw reads | Clean reads | Clean bases | Error rate (%) | Q20 (%)a | Q30 (%)b | GC content (%) | |
| 11-days post-infection | Infected | T111 | 68,999,052 | 65,632,084 | 9.84G | 2.00% | 96.08 | 90.32 | 49.66 |
| Infected | T112 | 70,544,072 | 67,074,478 | 10.06G | 2.00% | 96.03 | 90.21 | 49.42 | |
| Infected | T113 | 69,212,352 | 65,848,722 | 9.88G | 2.00% | 96.09 | 90.31 | 49.94 | |
| Control | C111 | 79,063,632 | 75,052,192 | 11.26G | 2.00% | 96.18 | 90.54 | 49.38 | |
| Control | C112 | 71,692,682 | 68,026,004 | 10.2G | 2.00% | 96.02 | 99.22 | 49.74 | |
| Control | C113 | 70,064,012 | 66,381,420 | 9.96G | 2.00% | 96.06 | 90.24 | 49.69 | |
| 33-day post infection | Infected | T331 | 68,042,008 | 66,719,442 | 10.01G | 2.00% | 96.71 | 91.86 | 48.57 |
| Infected | T332 | 71,371,072 | 69,232,194 | 10.38G | 2.00% | 94.96 | 87.87 | 49.55 | |
| Infected | T333 | 67,503,956 | 64,041,204 | 9.61G | 2.00% | 96.06 | 90.51 | 50.05 | |
| Control | C331 | 61,545,672 | 60,241,390 | 9.04G | 2.00% | 96.37 | 91.90 | 49.54 | |
| Control | C332 | 84,972,124 | 82,414,714 | 12.36G | 2.00% | 96.18 | 90.28 | 49.87 | |
| Control | C333 | 70,485,006 | 69,061,674 | 10.36G | 2.00% | 96.81 | 92.07 | 50.33 | |
FIGURE 2Results of RNA sequencing (RNA-seq) and differential expression analysis of transcripts. (A) Heat maps showing the hierarchical clustering of 936 and 2,081 differentially expressed transcripts (DETs) at 11 and 33 dpi, respectively. Each mouse group included three biological replicates. (B) Venn diagram showing the overlap of DETs in the brain of acutely- and chronically-infected mice, including upregulated and downregulated transcripts.
FIGURE 3Functional analysis of the differentially expressed transcripts (DETs). (A) The top 10 Gene Ontology (GO) terms and KEGG pathways of the DETs detected in the brain of acutely- and chronically-infected mice are shown. (B) Circos plot showing the relationship between GO terms and the corresponding genes. A number of genes related to immune response were enriched for biological process such as response to interferon-beta and interferon-gamma, T-cell activation, and positive regulation of cytokine production.
Description of the differentially expressed transcription factors (TFs) detected in the present study.
| Gene symbol | Description† | Expression |
| Atf3* | Activating transcription factor 3 | Upregulated |
| Batf2* | Basic leucine zipper transcription factor, ATF-like 2 | Upregulated |
| Bcl3* | B cell leukemia/lymphoma 3 | Upregulated |
| Eif2ak2* | Eukaryotic translation initiation factor 2-alpha kinase 2 | Upregulated |
| Ikzf1* | IKAROS family zinc finger 1 | Upregulated |
| Irf1* | Interferon regulatory factor 1 | Upregulated |
| Irf8* | Interferon regulatory factor 8 | Upregulated |
| Irf9* | Interferon regulatory factor 9 | Upregulated |
| Spi1* | Spleen focus forming virus (SFFV) proviral integration oncogene | Upregulated |
| Stat1* | Signal transducer and activator of transcription 1 | Upregulated |
| Stat2* | Signal transducer and activator of transcription 2 | Upregulated |
| Batf3# | Basic leucine zipper transcription factor, ATF-like 3 | Upregulated |
| Cd7# | CD7 antigen | Upregulated |
| Csf1# | Colony stimulating factor 1 (macrophage) | Upregulated |
| Elf1# | E74-like factor 1 | Upregulated |
| Elk3# | ELK3, member of ETS oncogene family | Upregulated |
| Ets1# | E26 avian leukemia oncogene 1, 5′ domain | Upregulated |
| Fli1# | Friend leukemia integration 1 | Upregulated |
| Gfi1# | Growth factor independent 1 transcription repressor | Upregulated |
| Hlx# | H2.0-like homeobox | Upregulated |
| Irf4# | Interferon regulatory factor 4 | Upregulated |
| Irf5# | Interferon regulatory factor 5 | Upregulated |
| Mcm6# | Minichromosome maintenance complex component 6 | Upregulated |
| Nfkb1# | Nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 | Upregulated |
| Pax6# | Paired box 6 | Upregulated |
| Pou2af1# | POU domain, class 2, associating factor 1 | Upregulated |
| Prdm1# | PR domain containing 1, with ZNF domain | Upregulated |
| Runx1# | Runt related transcription factor 1 | Upregulated |
| Runx3# | Runt related transcription factor 3 | Upregulated |
| Spib# | Spi-B transcription factor (Spi-1/PU.1 related) | Upregulated |
| Stat3# | Signal transducer and activator of transcription 3 | Upregulated |
| Tcf3# | Transcription factor 3 | Upregulated |
| Etv1# | Ets variant 1 | Downregulated |
| Fos# | FBJ osteosarcoma oncogene | Downregulated |
| Gtf2i# | General transcription factor II I | Downregulated |
| Pias3# | Protein inhibitor of activated STAT 3 | Downregulated |
| Tfap2a# | Transcription factor AP-2, alpha | Downregulated |
| Trps1# | Transcriptional repressor GATA binding 1 | Downregulated |
FIGURE 4Co-expression regulatory network of the differentially expressed TFs and their target genes. TFs are represented by orange circles and their gene targets are indicated by green circles. The connected lines are shown in pink (shared early and late infections), orange (early infection only), and blue (late infection only). The regulatory mode of the known interactions (i.e., activation and repression) are shown in Supplementary Table 3.
FIGURE 5Host-parasite interaction networks and function enrichment analysis of mouse brain genes. DETs were distinguished by acute infection only, shared acute and chronic infections, and chronic infection only. The top 10 biological processes GO terms of the interaction networks are shown.